ArticleInternational journal of cancer2018

Aneustat (OMN54) has aerobic glycolysis-inhibitory activity and also immunomodulatory activity as indicated by a first-generation PDX prostate cancer model.

Sifeng Qu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.